cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
3.1. Market Snapshot
3.2. Market Dynamics
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing utilization of plasma products across the globe in both existing and expanded indications
4.3.1.2. Improving access to plasma based therapies and increasing use of immunoglobulins in various therapeutic areas
4.3.1.3. Rising Geriatric Population Across the Globe
4.3.1.4. Increasing diagnosis of diseases that can be treated with plasma products
4.3.1.5. Increase in plasma collection
4.3.2. Restraints
4.3.2.1. High cost and limited reimbursement
4.3.2.2. Emergence of recombinant alternatives
4.3.3. Opportunities
4.3.3.1. Advance treatment options available for Hemophilia Patients
4.3.3.2. Advancements in process development for improved formulations
4.3.3.3. New products are currently in clinical trials
4.3.4. Challenges
4.3.4.1. Stringent Government Regulations
4.3.4.2. Emerging human pathogens and challenges in continuously supplying safe products through effective removal or inactivation
4.3.4.3. Maintaining strong global supply and manufacturing networks
4.4. Porter’s Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Threat of Substitutes
4.4.3. Bargaining Power of Customers
4.4.4. Bargaining Power of Suppliers
4.4.5. Industry Rivalry
5. Industry Trends
5.1. Fractionation capacities and geographical expansions
5.2. Fractionator-owned plasma collection centers
5.3. New indications for plasma products
6. Global Plasma Fractionation Market, by Product
6.1. Albumin
6.1.1. Overview
6.1.2. Market Sizing & Forecasting
6.2. Coagulation Factor Concentrates
6.2.1. Overview
6.2.2. Market Sizing & Forecasting
6.2.3. Factor IX
6.2.4. Factor VIII
6.2.5. Factor XIII
6.2.6. Fibrinogen Concentrates
6.2.7. Prothrombin Complex Concentrate
6.2.8. Von Willebrand Factor
6.3. Immunoglobulin
6.3.1. Overview
6.3.2. Market Sizing & Forecasting
6.3.3. Intravenous Immunoglobulin (IVIG)
6.3.4. Subcutaneous Immunoglobulin (SCIG)
6.4. Protease Inhibitors
6.4.1. Overview
6.4.2. Market Sizing & Forecasting
7. Global Plasma Fractionation Market, by Application
7.1. Critical Care
7.1.1. Overview
7.1.2. Market Sizing & Forecasting
7.2. Hemato-Oncology
7.2.1. Overview
7.2.2. Market Sizing & Forecasting
7.3. Hematology
7.3.1. Overview
7.3.2. Market Sizing & Forecasting
7.4. Neurology
7.4.1. Overview
7.4.2. Market Sizing & Forecasting
7.5. Pulmonology
7.5.1. Overview
7.5.2. Market Sizing & Forecasting
7.6. Rheumatology
7.6.1. Overview
7.6.2. Market Sizing & Forecasting
8. Global Plasma Fractionation Market, by End User
8.1. Academic & Research Institutes
8.1.1. Overview
8.1.2. Market Sizing & Forecasting
8.2. Clinical Research Laboratories
8.2.1. Overview
8.2.2. Market Sizing & Forecasting
8.3. Infectious Diseases
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
9. Global Plasma Fractionation Market, by Geography
9.1. Americas
9.1.1. Overview
9.1.2. Market Sizing & Forecasting
9.1.3. United States
9.2. Europe, Middle East & Africa
9.2.1. Overview
9.2.2. Market Sizing & Forecasting
9.2.3. United Kingdom
9.2.4. Germany
9.2.5. Saudi Arabia
9.3. Asia-Pacific
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. China
9.3.4. Japan
9.3.5. India
10. Competitive News Feed Analysis
11. Company Usability Profiles
11.1. Baxalta Incorporated
11.1.1. Business Overview
11.1.2. Business Strategy
11.1.3. Business SWOT Analysis
11.2. Bio Products Laboratory Ltd.
11.2.1. Business Overview
11.2.2. Business Strategy
11.2.3. Business SWOT Analysis
11.3. Biotest Aktiengesellschaft
11.3.1. Business Overview
11.3.2. Business Strategy
11.3.3. Business SWOT Analysis
11.4. CSL Limited
11.4.1. Business Overview
11.4.2. Business Strategy
11.4.3. Business SWOT Analysis
11.5. China Biologic Products Holdings, Inc.
11.5.1. Business Overview
11.5.2. Business Strategy
11.5.3. Business SWOT Analysis
11.6. Green Cross Corporation
11.6.1. Business Overview
11.6.2. Business Strategy
11.6.3. Business SWOT Analysis
11.7. Grifols, S.A.
11.7.1. Business Overview
11.7.2. Business Strategy
11.7.3. Business SWOT Analysis
11.8. Japan Blood Products Organization
11.8.1. Business Overview
11.8.2. Business Strategy
11.8.3. Business SWOT Analysis
11.9. Kedrion S.p.A.
11.9.1. Business Overview
11.9.2. Business Strategy
11.9.3. Business SWOT Analysis
11.10. LFB S.A.
11.10.1. Business Overview
11.10.2. Business Strategy
11.10.3. Business SWOT Analysis
11.11. Octapharma AG
11.11.1. Business Overview
11.11.2. Business Strategy
11.11.3. Business SWOT Analysis
11.12. Sanquin Blood Supply Foundation
11.12.1. Business Overview
11.12.2. Business Strategy
11.12.3. Business SWOT Analysis
11.13. Shanghai RAAS Blood Products Co., Ltd.
11.13.1. Business Overview
11.13.2. Business Strategy
11.13.3. Business SWOT Analysis
11.14. Shire PLC
11.14.1. Business Overview
11.14.2. Business Strategy
11.14.3. Business SWOT Analysis
12. Appendix
12.1. Top Reports
12.2. Author Details

LIST OF TABLES (44 TABLES)

TABLE 1. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. AMERICAS PLASMA FRACTIONATION MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 20. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 21. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 22. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 27. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 28. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 29. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 30. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 31. COMPETITIVE NEWS FEED ANALYSIS FOR BAXALTA INCORPORATED IN PLASMA FRACTIONATION MARKET
TABLE 32. COMPETITIVE NEWS FEED ANALYSIS FOR BIO PRODUCTS LABORATORY LTD. IN PLASMA FRACTIONATION MARKET
TABLE 33. COMPETITIVE NEWS FEED ANALYSIS FOR BIOTEST AKTIENGESELLSCHAFT IN PLASMA FRACTIONATION MARKET
TABLE 34. COMPETITIVE NEWS FEED ANALYSIS FOR CSL LIMITED IN PLASMA FRACTIONATION MARKET
TABLE 35. COMPETITIVE NEWS FEED ANALYSIS FOR CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. IN PLASMA FRACTIONATION MARKET
TABLE 36. COMPETITIVE NEWS FEED ANALYSIS FOR GREEN CROSS CORPORATION IN PLASMA FRACTIONATION MARKET
TABLE 37. COMPETITIVE NEWS FEED ANALYSIS FOR GRIFOLS, S.A. IN PLASMA FRACTIONATION MARKET
TABLE 38. COMPETITIVE NEWS FEED ANALYSIS FOR JAPAN BLOOD PRODUCTS ORGANIZATION IN PLASMA FRACTIONATION MARKET
TABLE 39. COMPETITIVE NEWS FEED ANALYSIS FOR KEDRION S.P.A. IN PLASMA FRACTIONATION MARKET
TABLE 40. COMPETITIVE NEWS FEED ANALYSIS FOR LFB S.A. IN PLASMA FRACTIONATION MARKET
TABLE 41. COMPETITIVE NEWS FEED ANALYSIS FOR OCTAPHARMA AG IN PLASMA FRACTIONATION MARKET
TABLE 42. COMPETITIVE NEWS FEED ANALYSIS FOR SANQUIN BLOOD SUPPLY FOUNDATION IN PLASMA FRACTIONATION MARKET
TABLE 43. COMPETITIVE NEWS FEED ANALYSIS FOR SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. IN PLASMA FRACTIONATION MARKET
TABLE 44. COMPETITIVE NEWS FEED ANALYSIS FOR SHIRE PLC IN PLASMA FRACTIONATION MARKET

LIST OF FIGURES (63 TABLES)

FIGURE 1. GLOBAL PLASMA FRACTIONATION MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PLASMA FRACTIONATION MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL PLASMA FRACTIONATION MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL PLASMA FRACTIONATION MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL PLASMA FRACTIONATION MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL PLASMA FRACTIONATION MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL PLASMA FRACTIONATION MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL PLASMA FRACTIONATION MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL PLASMA FRACTIONATION MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. PLASMA FRACTIONATION MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL PLASMA FRACTIONATION MARKET SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 12. GLOBAL PLASMA FRACTIONATION MARKET SHARE, BY PRODUCT, 2017 (%)
FIGURE 13. GLOBAL PLASMA FRACTIONATION MARKET SHARE, BY APPLICATION, 2017 (%)
FIGURE 14. GLOBAL PLASMA FRACTIONATION MARKET SHARE, BY END USER, 2017 (%)
FIGURE 15. GLOBAL PLASMA FRACTIONATION MARKET: KEY MARKET DYNAMICS
FIGURE 16. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 17. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 18. GLOBAL PLASMA FRACTIONATION MARKET OPPORTUNITY ANALYSIS, BY GEOGRAPHY, 2024 (USD MILLION)
FIGURE 19. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2017 (USD MILLION)
FIGURE 20. GLOBAL PLASMA FRACTIONATION MARKET OPPORTUNITY ANALYSIS, BY PRODUCT, 2024 (USD MILLION)
FIGURE 21. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2017 (USD MILLION)
FIGURE 22. GLOBAL PLASMA FRACTIONATION MARKET OPPORTUNITY ANALYSIS, BY APPLICATION, 2024 (USD MILLION)
FIGURE 23. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2017 (USD MILLION)
FIGURE 24. GLOBAL PLASMA FRACTIONATION MARKET OPPORTUNITY ANALYSIS, BY END USER, 2024 (USD MILLION)
FIGURE 25. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 26. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 27. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 28. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 29. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 30. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 31. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 32. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 33. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 34. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 35. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 36. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 37. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 38. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 39. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 40. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 41. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 42. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 43. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 44. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 45. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 46. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 47. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 48. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 49. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 50. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 51. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 52. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 54. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 55. GERMANY PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 56. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 57. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 58. CHINA PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 59. JAPAN PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 60. INDIA PLASMA FRACTIONATION MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 61. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL PLASMA FRACTIONATION MARKET, BY NEWS TYPE
FIGURE 62. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL PLASMA FRACTIONATION MARKET, BY COMPANY
FIGURE 63. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL PLASMA FRACTIONATION MARKET, BY YEAR

“Increasing utilization of plasma products across the globe in both existing and expanded indications is one of the factors largely attributing to the growth of plasma fractionation market globally”

The global plasma fractionation market is expected to grow from USD 17,921.67 million 2017 to USD 27,782.67 million by the end of 2024, at a Compound Annual Growth Rate (CAGR) of 6.46%.

Market Segmentation & Coverage: The report on global plasma fractionation market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the economies and geographies of the potential customer group can help to gain business acumen for better strategic decision making. Our market coverage across different industry verticals reveals the hidden truth about the strategies adopted by the players in different verticals and help the organization to decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.This research report categorizes the global plasma fractionation market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product
1. Albumin
2. Coagulation Factor Concentrates
3. Immunoglobulin
4. Protease Inhibitors

Based on Application
1. Critical Care
2. Hemato-Oncology
3. Hematology
4. Neurology
5. Pulmonology
6. Rheumatology

Based on End User
1. Academic & Research Institutes
2. Clinical Research Laboratories
3. Infectious Diseases

Based on Geography
1. Americas (United States)
2. Europe, Middle East & Africa (United Kingdom, Germany, and Saudi Arabia)
3. Asia-Pacific (China, Japan, and India)

Company Usability Profiles:
The plasma fractionation market research report provides the company usability profiles and analyze the business overview, business product offering, SWOT analysis, and business strategy of the following company:
1. Baxalta Incorporated
2. Bio Products Laboratory Ltd.
3. Biotest Aktiengesellschaft
4. CSL Limited
5. China Biologic Products Holdings, Inc.
6. Green Cross Corporation
7. Grifols, S.A.
8. Japan Blood Products Organization
9. Kedrion S.p.A.
10. LFB S.A.
11. Octapharma AG
12. Sanquin Blood Supply Foundation
13. Shanghai RAAS Blood Products Co., Ltd.
14. Shire PLC

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

Reasons to Buy:
1. To comprehensively understand of the plasma fractionation market with respect to major influencing factor such as drivers, restraints, opportunities and challenges
2. To strategically analyze each vertical and geographic sub-segment in the plasma fractionation market and its individual growth and its impact towards the growth of overall market




Summary:
Get latest Market Research Reports on Plasma Fractionation Market. Industry analysis & Market Report on Plasma Fractionation Market is a syndicated market report, published as The global plasma fractionation market is expected to grow from USD 17,921.67 million 2017 to USD 27,782.67 million by the end of 2024, at a CAGR of 6.46%.. It is complete Research Study and Industry Analysis of Plasma Fractionation Market market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$2,999.00
$3,999.00
$4,999.00
2,013.83
2,685.33
3,356.83
2,759.68
3,679.88
4,600.08
363,298.86
484,438.86
605,578.86
198,873.89
265,187.29
331,500.69
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report